STC
SRPT icon

SEI Trust Company’s Sarepta Therapeutics SRPT Stock Holding History

SEI Trust Company’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$108K Buy
+5,100
New +$115K ﹤0.01% 1458

Other funds holding SRPT

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SEI Trust Company's SRPT Position: Q3 2014 in Review

SEI Trust Company opened a new position in Sarepta Therapeutics (SRPT) in Q3 2014: 5,100 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1458 among its holdings.

123 funds tracked by Wall St. Rank hold SRPT as of Q3 2014.

  • SEI Trust Company held 5,100 shares of Sarepta Therapeutics worth $108K as of Q3 2014.
  • Sarepta Therapeutics was a new SEI Trust Company position in Q3 2014.
  • Sarepta Therapeutics made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1458 holding.
  • 123 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.